title: Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice.
abstract: Atherosclerosis develops and progresses spontaneously in apolipoprotein E-knockout (apoE-KO) mice. A direct consequence of atherosclerosis is an increase in vascular stiffness. Pulse wave velocity (PWV) has been used to assess the stiffness of large vessels and was found to be increased in patients with atherosclerosis. In the present study, aortic stiffness was assessed by PWV in 4- and 13-mo-old apoE-KO mice and age-matched controls (C57BL/6J). In 13-mo-old apoE-KO mice with extensive atherosclerotic lesions in the aorta (61 +/- 4%), PWV increased significantly (3.8 +/- 0.2 m/s) compared with controls (2.9 +/- 0.2 m/s). Endothelial nitric oxide (EDNO)-mediated vasorelaxation in response to ACh was markedly diminished in the aortic rings isolated from 13-mo-old apoE-KO mice compared with age-matched controls. In contrast, in 4-mo-old apoE-KO mice with only moderate atherosclerotic lesions in the aorta (23 +/- 5%), there were no significant changes in PWV and EDNO-mediated relaxation compared with controls. Blood pressure was not different among the four groups of mice. There were no significant differences in endothelium-independent vascular responses to sodium nitroprusside among different groups investigated. Histological evaluation revealed focal fragmentation of the elastic laminae in the aortic walls of 13-mo-old apoE-KO mice. These results demonstrate for the first time that aortic stiffness determined by PWV increases in 13-mo-old apoE-KO mice. Endothelial dysfunction and elastic destruction in vascular wall caused by atherosclerosis may have contributed.
authors.affiliation: Department of Pharmacology, Berlex Biosciences, Richmond, California 94804, USA. jim_wang@berlex.com
authors.forename: Y X
authors.initials: YX
authors.lastname: Wang
authors.forename: M
authors.initials: M
authors.lastname: Halks-Miller
authors.forename: R
authors.initials: R
authors.lastname: Vergona
authors.forename: M E
authors.initials: ME
authors.lastname: Sullivan
authors.forename: R
authors.initials: R
authors.lastname: Fitch
authors.forename: C
authors.initials: C
authors.lastname: Mallari
authors.forename: B
authors.initials: B
authors.lastname: Martin-McNulty
authors.forename: V
authors.initials: V
authors.lastname: da Cunha
authors.forename: A
authors.initials: A
authors.lastname: Freay
authors.forename: G M
authors.initials: GM
authors.lastname: Rubanyi
authors.forename: K
authors.initials: K
authors.lastname: Kauser
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D001018:Aortic Diseases / Q000503:physiopathology; D001057:Apolipoproteins E / Q000172:deficiency* / Q000235:genetics; D001161:Arteriosclerosis / Q000503:physiopathology; D004548:Elasticity; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000235:genetics; D011674:Pulse; D014664:Vasodilation; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D001057:Apolipoproteins E; D014665:Vasodilator Agents; D000109:Acetylcholine